Index of /content/mda/en/newsroom/2019/05/ipilimumab-heavy-immunotherapy-combination-with-nivolumab-produces-high-response-rate-in-metastatic-bladder-cancer/jcr_content/blog/
Name | Last Modified | Size |
---|---|---|
2025-05-28 04:28 | 103k |
Name | Last Modified | Size |
---|---|---|
2025-05-28 04:28 | 103k |